Komjathy Andrew
Insider CIK 1788465 · CATB Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 55,000 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 225,000 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer | 2026-01-23 | 2026-01-23 | 45 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer | 2026-01-23 | 2026-01-23 | 45 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer | 2026-01-23 | 2026-01-23 | 10 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-03-21 | 2025-03-25 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-02-08 | 2024-02-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | P Buy | 2021-11-19 | 2021-11-23 | 100 | $6.70 | $670 | 100 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-02-12 | 2020-02-14 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-09-18 | 2019-09-19 | 44,500 | — | $0 | 44,500 | SEC↗ |